Source: PharmaTimes
Area: News
The FDA is investigating cases of serious eye infections in patients in Miami who have been treated with repackaged intravitreal bevacizumab for wet age-related macular degeneration. The Agency is alerting healthcare professionals to reports of a cluster of serious eye infections, which investigators have traced to tainted injections from a single pharmacy, which was distributed to multiple eye clinics. To date, the FDA is aware of at least 12 patients in at least three of these clinics who had Streptococcus endophthalmitis eye infection, some of whom (Read more...)
Uncategorized